Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Jun 9, 2025 3:59:41 PM EDT

39.35USD-3.186%(-1.30)813,750

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 9, 2025 9:28:30 AM EDT

42.00USD+3.321%(+1.35)9,720

After-hours

Jun 9, 2025 4:07:30 PM EDT

39.60USD+0.969%(+0.38)103

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

287.57M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

1,273,600

Avg. Vol. 30 Day

1,107,394

Employees

Market Cap

287,566,544

Shares Out.

7,324,670

On/Off Exchange

37%/63%

6 Month Beta

0.55

1 Year Beta

0.74

2 Year Beta

0.82

3 Year Beta

1.00

52 Week Low

6.76

52 Week High

264.00

SMA50

23.21

SMA200

21.17

1 Week

+3.15%

1 Month

+108.50%

3 Month

+191.46%

6 Month

+109.50%

1 Year

-82.24%

2 Year

-99.33%

5 Year

-99.99%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $39.35, and today's volume is 813,750. TNXP is down -3.186% today. The 30 day average volume is 1,107,394. TNXP market cap is 287.57M with 7,324,670 shares outstanding.